Aspen Pharmacare Stock News

South African drugmaker Aspen Pharmacare on Tuesday concluded an agreement with Johnson & Johnson to package, sell and distribute the American group''s COVID-19 vaccines under its own brand in Africa.

PRG, AGESY, and APNHY have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2022

US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.

US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.

A strategic partnership that will enable Aspen Pharmacare to increase production capacity to meet the rising demands for COVID-19 vaccines in Africa. Co-financed by funds from the develoPPP programme of the German Government, digital technologies will enable faster and more efficient production while ensuring consistent product quality. In a joint project, Siemens South Africa, Aspen […] This post first appeared on African Business

The rand, on the up, surprised yesterday as it dipped below the R16 mark as the markets shrugged off the latest developments around the Covid-19 Omicron variant and the record unemployment numbers. Statistics South Africa yesterday revealed that the unemployment rate had escalated to 34.9 percent in the three months to September, the highest level since 2008. Stats SA said 660 000 people lost their jobs during the third quarter, with the number of discouraged work seekers dramatically increasing by 545 000. There are more than 7.6 million people of working age who are unemployed in South Africa. Despite this, the rand made a spectacular recovery following a retreat to R16.21 to the dollar earlier in the day as caution lingered in markets after Omicron sent the world in a panic. After starting the day at R16.11 to the dollar, the rand was unfazed by the unemployment reading, strengthening by 0.22 percent to R15.94 to the greenback by 5pm. Meanwhile, the domestic markets also pushed back against the risk off sentiment that spooked international markets after drugmaker Moderna warned about the Omicron variant.

Aspen Pharmacare has secured a deal with Johnson & Johnson to make and sell a

The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.

Aspen Pharmacare has entered into an agreement with Johnson & Johnson to manufacture and sell its own Covid-19 vaccine throughout Africa.

Promit Mukherjee JOHANNESBURG - South Africa has asked Johnson & Johnson and Pfizer to delay delivery of COVID-19 vaccines because it now has too much stock, health ministry officials said, as vaccine hesitancy slows an inoculation campaign. About 35% of South Africans are fully vaccinated, higher than in most other African nations, but half the government''s year-end target. It has averaged 106,000 doses a day in the past 15 days in a nation of 60 million people. Earlier this year the programme was slowed by insufficient doses. Now deliveries have been delayed due to oversupply, making the country an outlier in the continent where most are still starved of vaccines. Nicholas Crisp, deputy director-general of the Health Department, told Reuters that South Africa had 16.8 million doses in stock and said deliveries had been deferred. "We have 158 days'' stock in the country at current use," a spokesman for the Health Ministry said. "We have deferred some deliveries." They did not say when deliveries would now take place.

MILAN, Nov. 24, 2021 /PRNewswire/ -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and Aspen Pharmacare Holdings Limited ("Aspen"), a South African-headquartered global specialty and branded pharmaceutical company, announced today that the South Africa Health Products Regulatory Authority ("SAHPRA") has approved the first fixed combination of an ophthalmic quinolone antibiotic (levofloxacin) with an anti-inflammatory steroid (dexamethasone) eye drops solution indicated for the prevention and treatment of inflammation, and the prevention of infection associated with cataract surgery in adults. NTC granted the license and commercialization rights of its patented research and development product to Aspen for South Africa and other African countries and has provided full technical and regulatory support to Aspen which has secured market authorization for the product in South Africa. "We are proud of this strategic partnership with a leading company such as Aspen," Riccardo Carbucicchio, President and CEO of NTC, states. "We are excited to have achieved a regulatory approval in half the time compared to standard timeframes.

ACINO and Aspen Pharmacare Holdings Limited and its subsidiaries have signed an agreement for Acino to acquire six South African prescription medicines for over R1.8 billion. The acquired medicines are used for the treatment of gastroenterology, erectile dysfunction and cardiovascular diseases. The acquisition will further strengthen Acinos footprint in South Africa by expanding their offering in [] The post Aspens sales windfall totals R1,8bn appeared first on Cape Business News .

ASPEN PHARMACR (APNHY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2021 Results - Earnings Call Transcript

ASPEN PHARMACR (APNHY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it thro